https://www.selleckchem.com/pr....oducts/ono-7300243.h
The aim To explore the features of the congnitive (CD) and neurovegetative dysfunctions (NVD) of patients with different forms of non-alcoholic fatty liver disease NAFLD (nonalcoholicfatty hepatosis (NAFH) and non-alcoholic steatohepatitis (NASH)) and type 2 diabetes mellitus (T2DM), as well as their dynamics against the background of complex therapy using armadin (2-ethyl-6-methyl-3-hydroxypyridine succinate). Materials and methods 50 patients with NAFLD (24 patients with NAFH and 26 patients with NASH) and T2DM were examined. Dysf
Like
Comment
Share
